This is a preview of subscription content, log in via an institution to check access.
Notes
2016 US dollars
Reference
Moss HA, et al. Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in The United States.Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). JAMA Oncology : 7 Dec 2017. Available from: URL: http://dx.doi.org/10.1001/jamaoncol.2017.4211
Rights and permissions
About this article
Cite this article
Multimodal ovarian cancer screening cost effective in USA?. PharmacoEcon Outcomes News 793, 20 (2017). https://doi.org/10.1007/s40274-017-4580-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4580-9